UBE2N Antikörper (AA 20-138) (Biotin)
Kurzübersicht für UBE2N Antikörper (AA 20-138) (Biotin) (ABIN7174473)
Target
Alle UBE2N Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 20-138
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Ubiquitin-conjugating enzyme E2 N protein (20-138AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- UBE2N (Ubiquitin-Conjugating Enzyme E2N (UBE2N))
-
Andere Bezeichnung
- UBE2N
-
Hintergrund
-
Background: The UBE2V1-UBE2N and UBE2V2-UBE2N heterodimers catalyze the synthesis of non-canonical \'Lys-63\'-linked polyubiquitin chains. This type of polyubiquitination does not lead to protein degradation by the proteasome. Mediates transcriptional activation of target genes. Plays a role in the control of progress through the cell cycle and differentiation. Plays a role in the error-free DNA repair pathway and contributes to the survival of cells after DNA damage. Acts together with the E3 ligases, HLTF and SHPRH, in the \'Lys-63\'-linked poly-ubiquitination of PCNA upon genotoxic stress, which is required for DNA repair. Appears to act together with E3 ligase RNF5 in the \'Lys-63\'-linked polyubiquitination of JKAMP thereby regulating JKAMP function by decreasing its association with components of the proteasome and ERAD. Promotes TRIM5 capsid-specific restriction activity and the UBE2V1-UBE2N heterodimer acts in concert with TRIM5 to generate \'Lys-63\'-linked polyubiquitin chains which activate the MAP3K7/TAK1 complex which in turn results in the induction and expression of NF-kappa-B and MAPK-responsive inflammatory genes.
Aliases: Bendless like ubiquitin conjugating enzyme antibody, Bendless-like ubiquitin-conjugating enzyme antibody, BLU antibody, EC 6.3.2.19 antibody, Epididymis secretory protein Li 71 antibody, HEL-S-71 antibody, Human epidermoid carcinoma mRNA for ubiquitin-conjugating enzyme E2 similar to Drosophila bendless gene product complete cds antibody, MGC131857 antibody, MGC8489 antibody, UBC 13 antibody, Ubc13 antibody, UbCH ben antibody, UbcH-ben antibody, UbcH13 antibody, UBCHBEN antibody, Ube 2N antibody, Ube2n antibody, UBE2N_HUMAN antibody, Ubiquitin carrier protein N antibody, Ubiquitin conjugating enzyme E2 N antibody, Ubiquitin conjugating enzyme E2N (homologous to yeast UBC13) antibody, Ubiquitin conjugating enzyme E2N (UBC13 homolog yeast) antibody, Ubiquitin conjugating enzyme E2N antibody, Ubiquitin protein ligase N antibody, Ubiquitin-conjugating enzyme E2 N antibody, Ubiquitin-protein ligase N antibody, Yeast UBC13 homolog antibody
-
UniProt
- P61088
-
Pathways
- T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Toll-Like Receptors Cascades, Positive Regulation of Response to DNA Damage Stimulus, Ubiquitin Proteasome Pathway
Target
-